GRAIL, Inc. (GRAL)
65.96
+4.97
(+8.15%)
USD |
NASDAQ |
May 20, 16:00
65.98
+0.02
(+0.03%)
After-Hours: 20:00
GRAIL Free Cash Flow : -292.33M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Veracyte, Inc. | 155.34M |
| Insight Molecular Diagnostics, Inc. | -27.46M |
| Exagen, Inc. | -14.13M |
| bioAffinity Technologies, Inc. | -10.93M |
| Biodesix, Inc. | -25.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -86.99M |
| Cash from Investing (Quarterly) | -93.44M |
| Free Cash Flow Per Share (Quarterly) | -2.153 |
| Free Cash Flow to Equity (Quarterly) | -83.66M |
| Free Cash Flow to Firm (Quarterly) | -87.49M |
| Free Cash Flow Yield | -11.57% |